In MS, iron rim lesions tied to severe disability, more brain damage
A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim lesions.| Multiple Sclerosis News Today
A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim lesions.| Multiple Sclerosis News Today
Ocrevus (ocrelizumab) is an infusion therapy approved to treat adults with relapsing forms of MS and primary progressive MS.| Multiple Sclerosis News Today
The presence of two distinct chronic lesion markers on MRI is linked to faster disability progression in MS patients, researchers say.| Multiple Sclerosis News Today
Migraines affect around 24% of people with MS, and are about two times more likely to occur in these patients than in healthy individuals.| Multiple Sclerosis News Today
Several tests, including MRI and blood tests, can be used to diagnose MS. Learn more about testing and what to expect after a diagnosis.| Multiple Sclerosis News Today
Iaso Bio has received clearance from the FDA to start clinical trials to test its CAR T-cell therapy equecabtagene autoleucel in MS patients.| Multiple Sclerosis News Today
